Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00810251 · ClinicalTrials.gov registry record
MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry
A clinical trial of Flail Chest, sponsored by Legacy Biomechanics Laboratory.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00810251 is a study of Flail Chest that has completed, run by Legacy Biomechanics Laboratory. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00810251, a study of Flail Chest, has completed, sponsored by Legacy Biomechanics Laboratory.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.
Conditions Studied
Interventions
- DEVICE MatrixRIB (FDA Approval # K081623)
Study Locations (1)
Oregon
- Legacy Emanuel Hospital - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00810251
The ClinicalTrials.gov registry entry for NCT00810251 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Legacy Biomechanics Laboratory, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Flail Chest appearing as the primary indexed condition, and to 1 intervention - of which MatrixRIB (FDA Approval # K081623) is the first listed.
NCT00810251 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT00810251 about?
NCT00810251 is a clinical study titled "MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry". The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.
What is the current status of trial NCT00810251?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-12. Estimated completion is 2011-05.
What conditions does trial NCT00810251 study?
This clinical trial studies the following conditions: Flail Chest.
What interventions are being tested in trial NCT00810251?
The interventions under investigation include: MatrixRIB (FDA Approval # K081623) (DEVICE).
Who is sponsoring clinical trial NCT00810251?
This trial is sponsored by Legacy Biomechanics Laboratory, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00810251 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.